{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Camarillo",
      "address_1": "768 Calle Plano # B",
      "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.",
      "address_2": "",
      "product_quantity": "1,200 kits",
      "code_info": "Lots: PL520, PL521, PL522 and PL523",
      "center_classification_date": "20140131",
      "distribution_pattern": "CA",
      "state": "CA",
      "product_description": "Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML",
      "report_date": "20140212",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Fusion Pharmaceuticals, LLC",
      "recall_number": "D-1055-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "66139",
      "termination_date": "20140131",
      "more_code_info": "",
      "recall_initiation_date": "20130508",
      "postal_code": "93012-8555",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}